Drug: TYSABRI Injury: Multiple sclerosis Quarter: 2016Q3
Total Records: 77 Number of Pages: 4
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125982251 | TYSABRI | Multiple sclerosis | BIOGEN | 57.42 YR | F | 0 | 20160726 | US |
126005221 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160727 | US |
126066531 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160729 | US |
126101751 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160801 | US |
126102021 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160801 | US |
126172661 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160803 | US |
126283811 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160808 | US |
126354581 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160808 | US |
126367951 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160809 | US |
126390272 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160829 | US |
126393901 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160810 | US |
126400491 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160810 | US |
126435381 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160811 | US |
126436271 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160811 | US |
126466751 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160812 | US |
126471411 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160812 | US |
126510773 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160921 | US |
126511641 | TYSABRI | Multiple sclerosis | BIOGEN | 21.66 YR | F | 0 | 20160815 | US |
126581611 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160817 | US |
126594542 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160923 | US |
Total Records: 77 Number of Pages: 4